b' \x1f \x1d \x06 \x1b \x1a \x19 \x0b \x1d \x19 \x06 \x0e \x0b \x01 \x1b \x07 \x0b \x1d \x1b \x1a \x19 \x07 \x1b\x01 \x0b \x1d \x06 \x19 \x1c \x1e \x19 \x1c \x0b \x1b \x1d \x1c \x19 \x1a \x0e \x1f \x1f \x1b \x1a \x1aHIGHER INITIALA SMARTER PATH TO RELIEFDOSING FORImplementing higher initial dosages to combat increasingly potent substances facilitates a more e\x1ccient FASTER STABILITY stabilization process. Clinical data suggests that when patients begin at a dose appropriate for high-potency drug exposure, they are more likely to remain in treatment and the average dosage actually decreases over time with To meet the challenges ofpatients; conversely, starting at a lower dose often necessitates gradual increases to reach therapeutic stability todays environment, weand patients are more likely to prematurely discharge from the program.have adjusted original dosingDischarged | No Peak | Peaklevels to better combat the 30-39mghigh toxicity of fentanyl. This17.59% 41.05% 41.37%allows patients to stabilize much quicker, signicantly reducing withdrawal symptoms and cravings. As 60mgpatients nd their footing8.19% 43.9% 47.9%faster, they are better positioned to progress through treatment phasesDischarge rates more than double when starting at a lower dose, and earn take-homedecreasing the chances of successful recovery.privileges sooner. \x17\x18\x16\x15\x14\x13\x12\x1f\x17\x14\x12\x17\x15\x14\x12\x17\x11\x10HOLISTICKEY AREAS OF PATIENTIMPLEMENTATION STRATEGYEVALUATION FORASSESSMENT New Seasons implementation strategy emphasizes TAKE\x1fHOME Recovery Stability:Treatment duration, medicationteam-based decision-making tailored to the individual. consistency, relapse history Every patient case is reviewed by a multidisciplinary MEDICATIONSBehavioral Indicators: Punctuality, adherence toteam consisting of:Following the updatedclinic protocols, active recovery involvementMedical ProvidersSAMHSA guidelines, New Support Systems: Home environment and capacity CounselorsSeason has transitioned fromto safely manage take-home dosesAdministrative Sta\x1ethe rigid eight-point criteria to Clinical Engagement: Participation in therapy andThis team evaluates both benets and risks, ensuring a more exible six-pointrecovery planning that take-home decisions are informed, comprehensive, evaluation for take-homeWeekly/and focused on long-term recovery. 43.2%BiMonthly/ 41.8% 41.5% 42.1% 42.2% 42.3% 42.4% 42.3% 42.7%eligibility. Our medical teamsMonthly 40.3% 41% 41.4%now utilize a holistic decision-No Take38.1% 38% 37.7% 37.2% 38% 39.8%making process that prioritizesHomes 38.9% 38.4% 37% 34.8% 34.1% 34.9% 35.9% 35.3%Less Than34.3% 33.5%the "big picture." Rather than1 Week 32.9% 33.3% 32.1% 32.1% 32.7% 33.6%focusing solely on drug Weekly/35% 34.6% 32.9% 32.6% 32.5% 32.6% 33% 33.2%screen results, we now weighBiMonthly/ 31.2% 31.7% 32.1% 32.3% 29.6% 32.1%essential factors such asMonthly 27.6% 23.4%overall clinical engagement,Less Than24.4% 21.4%personal treatment progress,1 Week 23.7% 23.6% 23.5% 23.1% 22.8% 23% 18%and stability in daily life,16.1%No Take fostering a culture of trust andHomes 16.1% 16.2% 15.8% 16.2% 16.7% 16.9% 16.8% 16.8% 16.5% 16.2% 16% 15.9%patient-centered care. 2024 | 2025 page11'